Extract notice to the Minister
Harvoni
Common name / Subject : lédipasvir/sofosbuvir
Name of the manufacturer : Gilead
Form : Co.
Dosage : 90 mg – 400 mg
Name of the manufacturer : Gilead
Form : Co.
Dosage : 90 mg – 400 mg
Indication : Hépatite C chronique de génotype 1
INESSS' Recommendation
-
Minister's decisions
Modifier des indications reconnues aux listes des médicaments – Médicament d’exception
Evaluation published on March 01, 2018